Hua Wu's most recent trade in SAB Biotherapeutics Inc was a trade of 58,161 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 22, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
SAB Biotherapeutics Inc | Hua Wu | SVP Research & Product Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 58,161 | 58,161 | - | - | Employee Stock Option (right to buy) | |
SAB Biotherapeutics Inc | Hua Wu | SVP Research & Product Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 32,191 | 32,191 | - | - | Earnout Rights (Restricted Stock Units) | |
SAB Biotherapeutics Inc | Hua Wu | SVP Research & Product Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 14,540 | 14,540 | - | - | Employee Stock Option (right to buy) | |
SAB Biotherapeutics Inc | Hua Wu | SVP Research & Product Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 6,979 | 6,979 | - | - | Employee Stock Option (right to buy) | |
SAB Biotherapeutics Inc | Hua Wu | SVP Research & Product Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 4,653 | 4,653 | - | - | Employee Stock Option (right to buy) |